| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 33,956 | 37,402 | 35,978 | 37,463 | | Cost of Revenue | 7,300 | 8,255 | 8,929 | 9,134 | | | Gross Profit |
-
| 29,147 | 27,049 | 28,329 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,772 | 12,171 | 10,348 | 10,582 | | Non Recurring |
-
| (779) | 779 |
-
| | Others | 1,484 | 3,556 | 3,226 | 3,872 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 14,199 | 12,696 | 13,875 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 14,400 | 14,199 | 12,696 | 13,875 | | Interest Expense | 5,247 | 6,151 | 6,819 | 7,188 | | Income Before Tax | 9,153 | 8,048 | 5,877 | 6,687 | | Income Tax Expense | 3,723 | 3,245 | 2,394 | 1,927 | | Minority Interest | (187) | (165) |
-
| (30) | | | | Net Income From Continuing Ops | 5,243 | 4,638 | 3,483 | 4,730 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,243 | 4,638 | 3,483 | 4,730 | | Preferred Stock And Other Adjustments |
-
| 39 | (39) |
-
| | | Net Income Applicable To Common Shares | $5,243 | $4,677 | $3,444 | $4,730 |
|
0.51% Nasdaq 
Income Statement
